The Native Antigen Company is part of LGC Clinical Diagnostics - Learn More

0 Items
Select Page

Sign Up to Get Your Free eBook

The emergence and global proliferation of SARS-CoV-2 has required the rapid development of high quality in vitro diagnostics. Serological immunoassays in particular are required to determine patient immune status and epidemiological variables, support the development of countermeasures and alleviate the workload of centralised testing laboratories.

Central to the performance of any high quality immunoassay is the selection, development and application of high quality biological reagents. In this eBook, we discuss:

  • The Role of SARS-CoV-2 In Vitro Diagnostics
  • Challenges Associated with SARS-CoV-2 Diagnosis
  • Choosing Targets for Immunoassay Design
  • Reagent-Design Considerations
  • Selecting Appropriate Expression Systems

To get your free eBook, simply fill out the form below:

Preview of COVID-19 eBook

Would you like to be kept informed of the latest news and innovations from the infectious disease community? Please let us know if you would like us to contact you or not by selecting one of the options below.

11 + 6 =